Skip to main content Skip to section navigation Skip to footer
language Global website
Spotlight on uveal melanoma Bringing science to life News Careers Contact us
Immunocore Holdings plc
language Global website
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Our Values
    • Compliance and Transparency
    • Our CMC capabilities
  • Pipeline & Portfolio
    • Pipeline
    • Our Therapies
  • Science
    • Overview
    • What are Bispecific Therapies
    • T cells and the Immune System
    • Human Leukocyte Antigen System
    • Publications
  • Clinical Trials
    • Our Clinical Trials
    • What are Clinical Trials?
  • Investors
    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • Financials & Filings
    • Governance
    • IR Resources
  • Medical Information
    • Request medical information
    • US healthcare professionals
    • UK healthcare professionals
    • Grants and funding
  • Spotlight on uveal melanoma
  • Bringing science to life
  • News
  • Careers
  • Contact us

Events

Investors

Investors

  • Overview
  • News
    • Press Releases
    • Email Alerts
  • Events & Presentations
    • Events
    • Presentations
  • Stock Info
    • Quote and Chart
    • Historical Performance
    • Analyst Coverage
  • Financials & Filings
    • Financial Results
    • SEC Filings
    • Annual Reports
    • UK plc Annual Reports
    • Email Alerts
  • Governance
    • Overview
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contacts

  • Events & Presentations

  • Events
  • Presentations

Q4 2025 Earnings Call

Feb 25, 2026 8:00 am EST
Earnings Release
HTML PDF
Presentation
PDF
10-K Filing
HTML PDF
XBRL
ZIP
Annual Report
PDF
Proxy Statement
PDF
  • emailEmail Alerts
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
Immunocore Holdings plc
  • Visit us on Linkedin
  • Visit us on Youtube
©2026 Immunocore Holdings plc. All Rights Reserved.
Disclaimer Sitemap Compliance and Transparency Terms and Conditions
Privacy and Social Media Guidelines Cookies Payments and Disclosures Tax Policy Statement
Clinical Trials Gender Pay Gap Report Modern Slavery Statement

This is Immunocore's global website, intended for visitors seeking information on Immunocore's worldwide business.

If you are a medical professional and would like further information about Immunocore, our clinical research or clinical trials, please send an email to medical.information@immunocore.com (US) or medinfo.eu@immunocore.com (outside of US).

CM-GL-TAX-2400001
Date of production: August 2026

Visit our uveal melanoma disease education website (only available in certain countries)

You are about to leave Immunocore’s website and will be redirected to an external site. Immunocore is not responsible for the accuracy, security, or privacy policy of third-party platforms.

Continue Cancel